Karen Facey PhD CStat worked as a statistician in pharma and medicines regulation, before becoming CEO of the first national HTA Agency in Scotland. For the past 20 years, she has worked as an international consultant in HTA, with special interests in use of real world data, evaluation of rare disease treatments and patient involvement. She is senior advisor for HTA at FIPRA, providing secretariat to the payer-led learning network, RWE4Decisions. top
Edition speaker: 2019
Carla is a Health Technology Assessment Technician of the Innovation Unit at Hospital Clínic de Barcelona, a high-tech hospital and a reference for health care, research and medical training in Spain. In her everyday job, she works with different projects (technologies, services) assessing both the clinical and economic outcomes, to prove the value of health care technologies that are being developed inside the hospital as well as new technologies candidate to be introduced in the Hospital. Prior to this, Carla Fernandez was enrolled in d·Health Barcelona (Moebio, Biocat) a post-graduate program targeting innovation in healthcare, where she developed a 18-months project going through all the steps of the healthcare innovation cycle (detect a problem, create a solution, prototype, develop a business model and investor’s pitch to fund it). Contact with the healthcare innovation sector from a start-up perspective showed her a perspective that is useful in working in the HB-HTA department and which complemented her previous knowledge about innovation; the “seller/start-up” perspective was complemented by the “buyer/hospital” perspective. top
Edition speaker: 2016
Wolfgang is a member of the management board of Medtronic Germany GmbH and is responsible for the areas of health economics, market access and health policy. He develops and evaluates strategies for Medtronic therapies and products, the market launch and initiates with the decision makers from medicine, politics and health insurance the establishment of new forms of cooperation for patient care. Due to the wide product spectrum of Medtronic GmbH, Mr. Frisch has experience in the field of inpatient, and ambulatory care.
Mr. Frisch has been working in the medical technology industry for over 20 years. He was responsible for business development for Stryker GmbH & Co. KG in Germany, Austria and Switzerland and was responsible for the national key account and corporate account management of Dräger Medical AG. top
English (UK) 
Polski